CCMH
ACAD icon

Cornerstone Capital Management Holdings’s Acadia Pharmaceuticals ACAD Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-8,277
Closed -$231K – 1372
2016
Q1 		$231K Sell
8,277
-1,400
-14% -$30.5K ﹤0.01% 1181
2015
Q4 		$345K Sell
9,677
-523
-5% -$18.4K ﹤0.01% 1107
2015
Q3 		$337K Buy
10,200
+800
+9% +$33.3K ﹤0.01% 1110
2015
Q2 		$394K Sell
9,400
-200
-2% -$7.74K ﹤0.01% 1051
2015
Q1 		$313K Buy
9,600
+700
+8% +$24.1K ﹤0.01% 1102
2014
Q4 		$283K Buy
8,900
+1,400
+19% +$39.7K ﹤0.01% 1047
2014
Q3 		$186K Buy
+7,500
New +$175K ﹤0.01% 1110

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return